Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,640 | 28,880 | 19,241 | 11,288 | 8,305 |
| Marketable Securities | 7,762 | 19,111 | 36,510 | 62,508 | 82,575 |
| TOTAL | $45,253 | $49,488 | $58,038 | $77,359 | $92,146 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 224 | 707 |
| Other Non-Current Assets | 0 | 0 | 0 | 27 | 26 |
| TOTAL | $N/A | $N/A | $N/A | $251 | $733 |
| Total Assets | $45,253 | $49,488 | $58,038 | $77,610 | $92,879 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,435 | 3,204 | 4,711 | 9,803 | 12,908 |
| Accrued Expenses | 2,687 | 2,271 | 1,799 | 5,704 | 3,703 |
| TOTAL | $6,122 | $5,475 | $6,510 | $15,507 | $16,611 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,122 | $5,475 | $6,510 | $15,507 | $16,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,117 | 4,025 | 4,025 | 4,025 | 4,025 |
| Common Shares | 40 | 403 | 403 | 403 | 403 |
| Retained earnings | -133,427 | -128,195 | -120,299 | -109,015 | -94,151 |
| Other shareholders' equity | -57 | -211 | -392 | -467 | -225 |
| TOTAL | $39,131 | $44,013 | $51,528 | $62,103 | $76,268 |
| Total Liabilities And Equity | $45,253 | $49,488 | $58,038 | $77,610 | $92,879 |